S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Hypergrowth Stocks to Buy Now (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
5 Hypergrowth Stocks to Buy Now (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Hypergrowth Stocks to Buy Now (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
5 Hypergrowth Stocks to Buy Now (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Hypergrowth Stocks to Buy Now (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
5 Hypergrowth Stocks to Buy Now (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Hypergrowth Stocks to Buy Now (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
5 Hypergrowth Stocks to Buy Now (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
NASDAQ:CMAX

CareMax - CMAX Stock Forecast, Price & News

$2.67
+0.21 (+8.54%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.44
$2.83
50-Day Range
$2.46
$4.73
52-Week Range
$2.41
$8.47
Volume
1.18 million shs
Average Volume
1.09 million shs
Market Capitalization
$297.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.25

CareMax MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
134.1% Upside
$6.25 Price Target
Short Interest
Bearish
7.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$34,600 Bought Last Quarter
Proj. Earnings Growth
Decreasing
From ($0.46) to ($0.50) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars

Business Services Sector

207th out of 323 stocks

Nursing & Personal Care Facilities Industry

3rd out of 4 stocks


CMAX stock logo

About CareMax (NASDAQ:CMAX) Stock

CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.

Receive CMAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareMax and its competitors with MarketBeat's FREE daily newsletter.

CMAX Stock News Headlines

This Tech Stock Could be the Next Amazon
You can learn its name in Luke Lango’s latest report, 5 Hypergrowth Stocks for 2023. Claim Your Free Report Here. pixel
This Tech Stock Could be the Next Amazon
You can learn its name in Luke Lango’s latest report, 5 Hypergrowth Stocks for 2023. Claim Your Free Report Here. pixel
CareMax to Host Investor Day on March 13
CareMax: Penetrating The Large U.S. Healthcare Industry
CareMax, Inc. (CMAX) Q3 2022 Earnings Call Transcript
CareMax: Numbers Are Strong, Compelling Value On Offer
CareMax, Inc. (CMAX)
See More Headlines
Receive CMAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareMax and its competitors with MarketBeat's FREE daily newsletter.

CMAX Company Calendar

Last Earnings
11/15/2021
Today
4/02/2023
Next Earnings (Estimated)
5/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Nursing & personal care facilities
Sub-Industry
N/A
Current Symbol
NASDAQ:CMAX
Fax
N/A
Employees
1,270
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.25
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+134.1%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-37,800,000.00
Pretax Margin
-8.73%

Debt

Sales & Book Value

Annual Sales
$631.13 million
Cash Flow
$0.09 per share
Book Value
$5.80 per share

Miscellaneous

Free Float
94,711,000
Market Cap
$297.25 million
Optionable
Not Optionable
Beta
1.86

Key Executives

  • Mr. Carlos A. de SoloMr. Carlos A. de Solo (Age 44)
    Co-Founder, Pres, CEO & Director
    Comp: $864.47k
  • Mr. Kevin C. WirgesMr. Kevin C. Wirges (Age 43)
    Exec. VP, CFO & Treasurer
    Comp: $578.04k
  • Mr. Alberto R. de SoloMr. Alberto R. de Solo (Age 46)
    Exec. VP & COO
    Comp: $655.74k
  • Mr. Erick Anthony Fernandez (Age 44)
    Chief Accounting Officer
  • Samantha Swerdlin
    VP of Investor Relations
  • Meredith Longsworth
    Sr. VP, Gen. Counsel & Sec.
  • Teresa McMeans
    Chief Compliance Officer
  • Regla Wuilchrist
    Chief People Officer
  • Mr. Niberto Moreno M.D.
    Chief Medical Officer
  • Nicole Cable
    Chief Experience Officer













CMAX Stock - Frequently Asked Questions

Should I buy or sell CareMax stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CareMax in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CMAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CMAX, but not buy additional shares or sell existing shares.
View CMAX analyst ratings
or view top-rated stocks.

What is CareMax's stock price forecast for 2023?

3 analysts have issued 12-month price targets for CareMax's shares. Their CMAX share price forecasts range from $4.00 to $8.00. On average, they expect the company's stock price to reach $6.25 in the next twelve months. This suggests a possible upside of 134.1% from the stock's current price.
View analysts price targets for CMAX
or view top-rated stocks among Wall Street analysts.

How have CMAX shares performed in 2023?

CareMax's stock was trading at $3.65 at the beginning of the year. Since then, CMAX shares have decreased by 26.8% and is now trading at $2.67.
View the best growth stocks for 2023 here
.

Are investors shorting CareMax?

CareMax saw a increase in short interest in March. As of March 15th, there was short interest totaling 5,920,000 shares, an increase of 6.3% from the February 28th total of 5,570,000 shares. Based on an average trading volume of 690,700 shares, the days-to-cover ratio is presently 8.6 days. Approximately 7.6% of the shares of the stock are short sold.
View CareMax's Short Interest
.

When is CareMax's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our CMAX earnings forecast
.

How were CareMax's earnings last quarter?

CareMax, Inc. (NASDAQ:CMAX) released its quarterly earnings results on Monday, November, 15th. The company reported ($0.03) earnings per share for the quarter, topping analysts' consensus estimates of ($0.33) by $0.30. The business had revenue of $104.62 million for the quarter, compared to analysts' expectations of $110.99 million. CareMax had a negative trailing twelve-month return on equity of 13.28% and a negative net margin of 5.99%.

What ETF holds CareMax's stock ?

Global X Aging Population ETF holds 27,001 shares of CMAX stock, representing 0.15% of its portfolio.

What guidance has CareMax issued on next quarter's earnings?

CareMax issued an update on its FY 2023 earnings guidance on Thursday, March, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $700.00 million-$750.00 million, compared to the consensus revenue estimate of $816.14 million.

What is CareMax's stock symbol?

CareMax trades on the NASDAQ under the ticker symbol "CMAX."

How do I buy shares of CareMax?

Shares of CMAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareMax's stock price today?

One share of CMAX stock can currently be purchased for approximately $2.67.

How much money does CareMax make?

CareMax (NASDAQ:CMAX) has a market capitalization of $297.25 million and generates $631.13 million in revenue each year. The company earns $-37,800,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis.

How many employees does CareMax have?

The company employs 1,270 workers across the globe.

How can I contact CareMax?

CareMax's mailing address is 780 THIRD AVENUE 37TH FLOOR, NEW YORK NY, 10017. The official website for the company is www.caremax.com. The company can be reached via phone at 786-360-4768 or via email at ir@caremax.com.

This page (NASDAQ:CMAX) was last updated on 4/2/2023 by MarketBeat.com Staff